Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Bioorg Med Chem Lett. 2013 Sep 21;23(23):10.1016/j.bmcl.2013.09.043. doi: 10.1016/j.bmcl.2013.09.043

Figure 2.

Figure 2

Cell viability studies of proteasome inhibitors against RPMI 8226 (A) and 5TGM1 (B)

Effect of proteasome inhibitor on myeloma cell proliferation. Proliferation assay of RPMI8226 (A) and 5TGM1 (B) myeloma cells were treated with different concentrations (1–18 nM) of proteasome inhibitors for 72h. Results are mean of three independent experiments.